Metraipolis › archive › dc_8601b3394aea

NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer — Europe PMC PMID:42476973

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42476973
DOI
10.1038/s41392-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-10-08T04:33:19.135Z
SHA-256 of the archived text
bf6011523e1af82fb40fdc79a9675890f2fa851752398067a49de83185c625cf
Stable URL of this page
https://metraipolis.com/documento/dc_8601b3394aea

How to cite

NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer — Europe PMC PMID:42476973 — Europe PMC (en), https://europepmc.org/article/MED/42476973 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8601b3394aea (Metraipolis archive dc_8601b3394aea, sha256 bf6011523e1af82fb40fdc79a9675890f2fa851752398067a49de83185c625cf)
BibTeX
@misc{dc8601b3394aea,
  title = {NOD1/2 signaling in macrophages drives adaptive immune resistance in cancer — Europe PMC PMID:42476973},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42476973},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8601b3394aea; sha256 bf6011523e1af82fb40fdc79a9675890f2fa851752398067a49de83185c625cf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42476973. Agents can read the archived copy with the MCP tool read_document.